News
US regulators rejected a skin cancer treatment from Replimune Group Inc. in another sign of the agency’s new leadership ...
3h
The Brighterside of News on MSNTwo FDA-approved cancer drugs significantly reverse Alzheimer's diseaseAlzheimer’s disease remains one of medicine’s toughest challenges, affecting millions and costing trillions of dollars ...
An analysis from the Congressional Budget Office warns that cuts to the National Institutes of Health and FDA drug reviews could significantly reduce the number of new medications reaching the U.S.
Scientists at UCSF and Gladstone Institutes have identified cancer drugs that promise to reverse the changes that occur in ...
Scientists at UC San Francisco and Gladstone Institutes have identified cancer drugs that promise to reverse the changes that ...
Sarepta Therapeutics is pausing shipments of its gene therapy for muscular dystrophy following several patient deaths that ...
Study harnesses a cell-type-specific, multi-target drug discovery strategy grounded in human data and real-world evidence.
FDA Commissioner Marty Makary, M.D., has made his pick for the next director of the FDA’s Center for Drug Evaluation and ...
Study finds two cancer drugs could slow Alzheimer's disease in mice, offering promise for reversing symptoms in humans.
The Hill on MSN4h
FDA commissioner stirs debate over hormone therapy for menopauseA Food and Drug Administration expert panel has reignited a debate over whether hormone therapy should be used to treat ...
George Francis Tidmarsh, MD, PhD, founding co-director of Stanford’s Master of Translational Research and Applied Medicine ...
U.S. Food & Drug Administration (FDA) warning letter to a prominent wellness product and services company offers a blunt reminder ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results